目的:通过分枝杆菌热休克蛋白保守性B细胞表位多次免疫小鼠,研究热休克蛋白65(HSP65)与动脉粥样硬化之间的关系.方法:PCR技术扩增出HSP65上与动脉粥样硬化密切相关的6个B细胞表位基因.将这6个表位的基因分成两组,分别与CTB基因相融合并在大肠杆菌中表达.两种蛋白表达产物经过分离、纯化、混合复性,复性后的蛋白经GM1-ELISA证明可在体外自组装成5聚体.用复性后的重组蛋白小剂量多次滴鼻免疫ICR小鼠,然后用大量的HSP65蛋白经皮下免疫,采集血样,ELISA检测小鼠血清中抗HSP65的抗体.结果:重组蛋白预免疫ICR小鼠后,可以使免疫组较对照组对随后的大量HSP65刺激产生更加强烈的免疫反应.结论:分枝杆菌热休克蛋白保守性B细胞表位经鼻黏膜的反复预免疫强化了小鼠对随后攻击性免疫的反应. 将这6个表位的基因分成两组,分别与CTB基因相融合并在大肠杆菌中表达.两种蛋白表达产物经过分离、纯化、混合复性,复性后的蛋白经GMI-ELISA证明可在体外自组装成5聚体.用复性后的重组蛋白小剂量多次滴鼻免疫ICR小鼠,然后用大量的HSP65蛋白经皮下免疫,采集血样,ELISA检测小鼠血清中抗HSP65的抗体.结果: 组蛋白预免疫ICR小鼠后,可以使免疫组较对照组对随后的大量HSP65刺激产生更加强烈的免疫反应.结论:分枝杆菌热休克蛋白保守性B细胞表位经鼻黏膜的反复预免疫强化了小鼠对随后攻击性免疫的反应. 将这6个表位的基因分成两组,分别

[1] POCKLEY A G. Heat shock proteins,inflammation,and cardiovascular disease. 2002(8). doi:10.1161/hc0802.103729
[2] XU Q. Role of heat shock proteins in atherosclerosis. 2002(10). doi:10.1161/01.ATV.0000029720.59649.50
[3] GERGE J, SHOENFELD Y, AFEK A. Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein-65, 1999(3)
[4] QI G, MAO D, WU J. Long-lasting specific antibodies against CETP induced by subcutaneous and mueosal administration of a 26-amino acid CETP epitope carried by heat shock protein 65 kDa in the absence of adjuvants. 2004(23-24). doi:10.1016/j.vaccine.2004.01.060
[5] QI G, WU J, YANG X. Expressing and purifying an antiatherosclerosis polypeptide vaccine in Escherichia coli. 2004(2). doi:10.1016/j.pep.2004.04.005
[6] PERSCHINKA H, MAYR M, MILLONIG G. Cross-reactive B-cell epitopes of microbial and human heat shock protein 60/65 in atherosclerosis. 2003(6)
[7] METZLER B, SCHETT G, KLEINDIENST R. Epitope specificity of anti-heat shock protein 65/60 serum antibodies in atherosclerosis. 1997(3)
[8] RUDIN A, RIISE G C, HOLMGREN J. Antibody responses in the lower respiratory tract and male urogenital tract in humans after nasal and oral vaccination with cholera toxin B subunit, 1999(6)
[9] BERGQUIST C, JOHANSSON E V, LAGERGARD T. Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina, 1997(7)
[10] TAMURA S, SAMEGAI Y, KURATA H. Protection against influenza virus infection by vaccine inoculated intranasal with cholera toxin B subunit. 1998(5). doi:10.1016/0264-410X(88)90140-5
[11] CZERKINSKY C, RUSSELL M W, LYCKE N. Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses insalivary gland sandextramucosal tissues, 1989(4)
[12] BRILES D E, ADES E, PATON J C. Hollingshead,Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae. 2000(2). doi:10.1128/IAI.68.2.796-800.2000
[13] PASCALE J M, SHAW M M, DURANT P J. Intranasal immunization confers protection against murine Pneumocystis carinii lung infection, 1999(2)
[14] LAMB J R, BAL V, MENDEZ-SAMPERIO A. Stress proteins may provide a link between the immune respunse to infection and auto-immunity. 1989(2). doi:10.1093/intimm/1.2.191